SCHEMBL17217730

SCHEMBL17217730

Fc1ccc(CON=[C]c2ccccc2)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.39
▸ MAOA P21397 1/20 0.38
▸ KDM1A O60341 1/20 0.38
▸ HTT P42858 2/20 0.37
▸ PPARA Q07869 1/20 0.36
▸ FFAR1 O14842 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ MME P08473 1/20 0.32
▸ ACE P12821 1/20 0.32
▸ CPA1 P15085 1/20 0.32
▸ ACE2 Q9BYF1 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17217729 1.00 MAOB (0.39) MAOBMAOAKDM1AHTTPPARA
SCHEMBL17217021 0.88 MAOB (0.38) MAOBMAOAHTTPPARAALDH1A1
SCHEMBL17217019 0.88 MAOB (0.38) MAOBMAOAHTTPPARAALDH1A1
SCHEMBL17216287 0.87 MAOB (0.40) MAOBMAOAPPARASMN1; SMN2HTR6
SCHEMBL17216289 0.87 MAOB (0.40) MAOBMAOAPPARASMN1; SMN2HTR6
SCHEMBL17218051 0.86 CNR1 (0.39) MAOBMAOADRD4L3MBTL1CNR1
SCHEMBL17218049 0.86 CNR1 (0.39) MAOBMAOADRD4L3MBTL1CNR1
SCHEMBL17218006 0.85 MAOB (0.41) MAOBMAOA
SCHEMBL17218003 0.85 MAOB (0.41) MAOBMAOA
SCHEMBL17218985 0.85 CCR5 (0.39) MAOBMAOAHTTPPARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940012-B1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-30 — — EP disclosed
US-9560850-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-07 — — US disclosed
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 — — US disclosed
EP-2940012-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF Sumitomo Chemical Company Limited (JP) 2015-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF RTN3, CYP51A1, TCOF1 MAOB 3611/4885MAOA 3360/4885KDM1A 1826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback